Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection

Clinical Infectious Diseases

Volumn 58, Issue 4, 2014, Pages 564-572

  Slyker, Jennifer ^a   Farquhar, Carey ^a   Atkinson, Claire ^d   Ásbjörnsdóttir, Kristjana ^a   Roxby, Alison ^a   Drake, Alison ^a   Kiarie, James ^g   Wald, Anna ^a   Boeckh, Michael ^a,c   Richardson, Barbra ^a,b   Odem Davis, Katherine ^b   John Stewart, Grace ^a   Emery, Vincent ^e,f  

^a Department of Global Health ^*  (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c USA   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF SURREY   (United Kingdom)

^g UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

compartmentalization; cytomegalovirus; human immunodeficiency virus; neonates; opportunistic infection

Indexed keywords

VIRUS DNA;

ARTICLE; BREAST MILK; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT DISEASE; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PREGNANCY; PRIORITY JOURNAL; UTERINE CERVIX MUCUS; VIRUS REPLICATION; VIRUS TRANSMISSION; COMPLICATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; ISOLATION AND PURIFICATION; NEWBORN; PLASMA; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; TRANSMISSION; UTERINE CERVIX; VERTICAL TRANSMISSION; VIROLOGY; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CERVIX UTERI; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN; PLASMA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 84893217835     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit727     Document Type: Article

References (37)

1. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev 2013; 26:86-102.
2. Kurath S, Halwachs-Baumann G, Muller W, Resch B. Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review. Clin Microbiol Infect 2010; 16:1172-8.
3. Gompels UA, Larke N, Sanz-Ramos M, et al. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis 2012; 54:434-42.
4. Goelz R, Meisner C, Bevot A, Hamprecht K, Kraegeloh-Mann I, Poets CF. Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk. Arch Dis Child Fetal Neonatal Ed 2013; 98:F430-33.
5. Kovacs A, Schluchter M, Easley K, et al. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women: Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 1999; 341: 77-84.
6. Nigro G, Krzysztofiak A, Gattinara GC, et al. Rapid progression of HIV disease in children with cytomegalovirus DNAemia. Aids 1996; 10: 1127-33.
7. Gerna G, Baldanti F, Revello MG. Pathogenesis of human cytomegalovirus infection and cellular targets. Hum Immunol 2004; 65:381-6.
8. Chandler SH, Alexander ER, Holmes KK. Epidemiology of cytomegaloviral infection in a heterogeneous population of pregnant women. J Infect Dis 1985; 152:249-56.
9. Shen CY, Chang SF, Yen MS, Ng HT, Huang ES, Wu CW. Cytomegalovirus excretion in pregnant and nonpregnant women. J Clin Microbiol 1993; 31:1635-6.
10. Stagno S, Reynolds D, Tsiantos A, et al. Cervical cytomegalovirus excretion in pregnant and nonpregnant women: suppression in early gestation. J Infect Dis 1975; 131:522-7.
11. McGalie CE, McBride HA, McCluggage WG. Cytomegalovirus infection of the cervix: morphological observations in five cases of a possibly under-recognised condition. J Clin Pathol 2004; 57:691-4.
12. Vochem M, Hamprecht K, Jahn G, Speer CP. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 1998; 17:53-8.
13. Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001; 357:513-8.
14. Njeru DG, Mwanda WO, Kitonyi GW, Njagi EC. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi. East Afr Med J 2009; 86:S58-61.
15. Slyker JA, Lohman-Payne BL, Rowland-Jones SL, et al. The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS 2009; 23:117-24.
16. Slyker JA, Lohman-Payne BL, John-Stewart GC, et al. Acute cytomegalovirus infection in Kenyan HIV-infected infants. Aids 2009; 23:2173-81.
17. Drake AL, Roxby AC, Ongecha-Owuor F, et al. Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial. J Infect Dis 2012; 205: 366-75.
18. Emery S, Bodrug S, Richardson BA, et al. Evaluation of performance of the Gen-Probe HIV type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000; 38:2688-95.
19. Panteleeff DD, John G, Nduati R, et al. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999; 37:350-3.
20. Wamalwa DC, Obimbo EM, Farquhar C, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr 2010; 10:33.
21. Mattes FM, Hainsworth EG, Hassan-Walker AF, et al. Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis 2005; 191:89-92.
22. Wamalwa D, Benki-Nugent S, Langat A, et al. Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed. Pediatr Infect Dis J 2012; 31:729-731.
23. van der Strate BW, Harmsen MC, Schafer P, et al. Viral load in breast milk correlates with transmission of human cytomegalovirus to preterm neonates, but lactoferrin concentrations do not. Clin Diagn Lab Immunol 2001; 8:818-21.
24. Jim WT, Shu CH, Chiu NC, et al. High cytomegalovirus load and prolonged virus excretion in breast milk increase risk for viral acquisition by very low birth weight infants. Pediatr Infect Dis J 2009; 28:891-4.
25. Farquhar C, Nduati R, Haigwood N, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immune Defic Syndr 2005; 40:494-7.
26. Fidouh-Houhou N, Duval X, Bissuel F, et al. Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis 2001; 33:1406-11.
27. Reynolds DW, Stagno S, Hosty TS, Tiller M, Alford CA Jr. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 1973; 289:1-5.
28. Hamprecht K,Witzel S, Maschmann J, et al. Rapid detection and quantification of cell free cytomegalovirus by a high-speed centrifugationbased microculture assay: comparison to longitudinally analyzed viral DNA load and pp67 late transcript during lactation. J Clin Virol 2003; 28:303-316.
29. Yasuda A, Kimura H, Hayakawa M, et al. Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. Pediatrics 2003; 111:1333-6.
30. Sabbaj S, Ghosh MK, Edwards BH, et al. Breast milk-derived antigenspecific CD8+ T cells: an extralymphoid effector memory cell population in humans. J Immunol 2005; 174:2951-6.
31. Ehlinger EP, Webster EM, Kang HH, et al. Maternal cytomegalovirusspecific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants. J Infect Dis 2011; 204:1672-82.
32. Shacklett BL, Cox CA, Sandberg JK, Stollman NH, Jacobson MA, Nixon DF. Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection. J Virol 2003; 77:5621-31.
33. Gantt S, Carlsson J, Shetty AK, et al. Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis. Aids 2008; 22:1453-60.
34. Sheth PM, Danesh A, Sheung A, et al. Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. J Infect Dis 2006; 193:45-8.
35. Lurain NS, Robert ES, Xu J, et al. HIV type 1 and cytomegalovirus coinfection in the female genital tract. J Infect Dis 2004; 190:619-23.
36. Frederick T, Homans J, Spencer L, et al. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIVexposed infants. Clin Infect Dis 2012; 55:877-84.
37. Guibert G, Warszawski J, Le Chenadec J, et al. Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy. Clin Infect Dis 2009; 48:1516-25.